TABLE 1.

Who Are Good Candidates for Transitioning to FRC Therapy?

✔ Patients with insufficient glycemic control on diet and exercise, oral antihyperglycemic agents, basal insulin, or a GLP-1 receptor agonist
✔ Patients with insulin requirements within the available range of FRC dosing
✔ Patients requiring a ratio of insulin to GLP-1 receptor agonist that is compatible with the available FRC medications
✔ Patients who prefer a single daily injection to multiple daily injections
✔ Patients who are concerned about weight gain
✔ Patients with concerns about the risk of hypoglycemia with increasing insulin dosage
✔ Patients who are already taking a GLP-1 receptor agonist and would like to reduce associated GI adverse events